Showing results (191-200 of 620) with videos related to
Sort By:
Pageof 62
Immunobiology|October 7, 2016
Non-redundant role of the chemokine receptor CX3CR1 in the anti-inflammatory function of gut macrophagesG Marelli, C Belgiovine, A Mantovani, et al.Blood|October 15, 1992
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial productsF Colotta, F Re, N Polentarutti, et al.Immunology Today|July 1, 1992
The origin and function of tumor-associated macrophagesA Mantovani, B Bottazzi, F Colotta, et al.Immunology Today|December 1, 1994
The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1F Colotta, S K Dower, J E Sims, et al.Clinical and Experimental Immunology|November 1, 1981
Cytotoxicity of human peripheral blood monocytes against Trichomonas vaginalisA Mantovani, N Polentarutti, G Peri, et al.European Journal of Immunology|December 1, 1994
Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cellsM Muzio, M Sironi, N Polentarutti, et al.Journal of Psychiatric Research|January 1, 1984
Physiological and pathological influences of central nervous system on the immune system: a critical appraisalG Forni, M Bindoni, A Santoni, et al.Cancer Treatment Reports|January 1, 1978
Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerateA Vecchi, M Cairo, A Mantovani, et al.Journal of Leukocyte Biology|July 1, 1987
Defective production of reactive oxygen intermediates by tumor-associated macrophages exposed to phorbol esterP Ghezzi, A Erroi, R Acero, et al.Immunopharmacology and Immunotoxicology|January 1, 1989
Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cellsP Allavena, F Peccatori, D Maggioni, et al.Pageof 62